c-erbB-2 Protein in Bladder Cancer
Author Information
Author(s): C. Wright, K. Mellon, D.E. Neal, P. Johnston, I.P. Corbett, C.H.W. Horne
Primary Institution: University of Newcastle upon Tyne, Royal Victoria Infirmary
Hypothesis
The study investigates the relationship between c-erbB-2 protein expression and clinical outcomes in bladder cancer.
Conclusion
c-erbB-2 protein overexpression occurs in a significant proportion of bladder carcinomas and may be associated with muscle invasive tumors.
Supporting Evidence
- 16 out of 44 bladder tumors showed c-erbB-2 protein expression.
- Four of the five tumors with intense staining were muscle invasive.
- Previous studies have linked c-erbB-2 overexpression to poorer prognosis in breast cancer.
Takeaway
This study looked at a protein called c-erbB-2 in bladder cancer and found that some tumors have a lot of it, which might mean they are more serious.
Methodology
The study used immunohistochemical techniques to assess c-erbB-2 protein levels in bladder cancer specimens.
Limitations
The study's findings are based on a relatively small sample size and may not be generalizable.
Participant Demographics
29 male and 15 female patients with a median age of 69 years.
Want to read the original?
Access the complete publication on the publisher's website